ICCAS OpenIR
RNAi therapeutic and its innovative biotechnological evolution
Weng, Yuhua; Xiao, Haihua; Zhang, Jinchao; Liang, Xing-Jie; Huang, Yuanyu
2019-09-01
Source PublicationBIOTECHNOLOGY ADVANCES
ISSN0734-9750
Volume37Issue:5Pages:801-825
AbstractRecently, United States Food and Drug Administration (FDA) and European Commission (EC) approved Alnylam Pharmaceuticals' RNA interference (RNAi) therapeutic, ONPATTRO (TM) (Patisiran), for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hAITR) amyloidosis in adults. This is the first RNAi therapeutic all over the world, as well as the first FDA-approved treatment for this indication. As a milestone event in RNAi pharmaceutical industry, it means, for the first time, people have broken through all development processes for RNAi drugs from research to clinic. With this achievement, RNAi approval may soar in the coming years. In this paper, we introduce the basic information of ONPATTRO and the properties of RNAi and nucleic acid therapeutics, update the clinical and preclinical development activities, review its complicated development history, summarize the key technologies of RNAi at early stage, and discuss the latest advances in delivery and modification technologies. It provides a comprehensive view and biotechnological insights of RNAi therapy for the broader audiences.
DOI10.1016/j.biotechadv.2019.04.012
Indexed BySCI
Language英语
WOS IDWOS:000477917000012
EI Accession Number1873-1899
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.iccas.ac.cn/handle/121111/82619
Collection中国科学院化学研究所
AffiliationChinese Acad Sci, Inst Chem, Beijing 100190, Peoples R China
Recommended Citation
GB/T 7714
Weng, Yuhua,Xiao, Haihua,Zhang, Jinchao,et al. RNAi therapeutic and its innovative biotechnological evolution[J]. BIOTECHNOLOGY ADVANCES,2019,37(5):801-825.
APA Weng, Yuhua,Xiao, Haihua,Zhang, Jinchao,Liang, Xing-Jie,&Huang, Yuanyu.(2019).RNAi therapeutic and its innovative biotechnological evolution.BIOTECHNOLOGY ADVANCES,37(5),801-825.
MLA Weng, Yuhua,et al."RNAi therapeutic and its innovative biotechnological evolution".BIOTECHNOLOGY ADVANCES 37.5(2019):801-825.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Weng, Yuhua]'s Articles
[Xiao, Haihua]'s Articles
[Zhang, Jinchao]'s Articles
Baidu academic
Similar articles in Baidu academic
[Weng, Yuhua]'s Articles
[Xiao, Haihua]'s Articles
[Zhang, Jinchao]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Weng, Yuhua]'s Articles
[Xiao, Haihua]'s Articles
[Zhang, Jinchao]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.